IFNG and Alzheimer disease: Along these lines, an upregulation of the serum Th2 markers was found in both Asian and European American AD patients, together with a lower expression of Th1 markers (IFNγ, CCL2, CCL3, CCL4) and increased Th22 activation in Asian patients compared to European American.